Clinical Trial Update: GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial exploring bendamustine as GVHD prophylaxis after transplantation in refractory leukemia, reported in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Mixed-lineage Acute Leukemias

Drugs mentioned

• Bendamustine (Bendamustine)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED